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Mannose-6-phosphate regulates destruction  
of lipid-linked oligosaccharides
ABSTRACT Mannose-6-phosphate (M6P) is an essential precursor for mannosyl glycoconju-
gates, including lipid-linked oligosaccharides (LLO; glucose3mannose9GlcNAc2-P-P-dolichol) 
used for protein N-glycosylation. In permeabilized mammalian cells, M6P also causes specific 
LLO cleavage. However, the context and purpose of this paradoxical reaction are unknown. 
In this study, we used intact mouse embryonic fibroblasts to show that endoplasmic reticulum 
(ER) stress elevates M6P concentrations, leading to cleavage of the LLO pyrophosphate link-
age with recovery of its lipid and lumenal glycan components. We demonstrate that this M6P 
originates from glycogen, with glycogenolysis activated by the kinase domain of the stress 
sensor IRE1-α. The apparent futility of M6P causing destruction of its LLO product was re-
solved by experiments with another stress sensor, PKR-like ER kinase (PERK), which attenu-
ates translation. PERK’s reduction of N-glycoprotein synthesis (which consumes LLOs) stabi-
lized steady-state LLO levels despite continuous LLO destruction. However, infection with 
herpes simplex virus 1, an N-glycoprotein-bearing pathogen that impairs PERK signaling, not 
only caused LLO destruction but depleted LLO levels as well. In conclusion, the common 
metabolite M6P is also part of a novel mammalian stress-signaling pathway, responding to 
viral stress by depleting host LLOs required for N-glycosylation of virus-associated polypep-
tides. Apparently conserved throughout evolution, LLO destruction may be a response to a 
variety of environmental stresses.
INTRODUCTION
An essential function of the eukaryotic endoplasmic reticulum (ER) is 
asparagine-linked (N-linked) glycosylation of nascent ER polypep-
tides. In the ER, N-linked glycans on the newly synthesized glycopro-
teins are processed by specific ER-associated glycosidases. The 
various processed glycans then interact with important ER-resident 
glycan-binding proteins (lectins) involved in protein folding, assem-
bly, quality control, and, if necessary ER-associated degradation 
(ERAD). N-linked glycosylation absolutely requires the synthesis of a 
lipid-linked oligosaccharide (LLO) bearing a 14-sugar glycan in pyro-
phosphate linkage to dolichol (Dol), glucose3mannose9GlcNAc2-P-
P-dolichol (G3M9Gn2-P-P-Dol; Figure 1). The LLO is utilized by the 
multi-subunit enzyme oligosaccharyltransferase (OT) for transfer of 
G3M9Gn2 glycans to selected asparagine residues within the context 
Asn-X-Ser/Thr on newly synthesized polypeptide chains within the 
ER lumen. An LLO intermediate (M5Gn2-P-P-Dol) is first synthesized 
by seven cytosolic glycosyltransferase reactions upon a Dol-phos-
phate (Dol-P) carrier lipid, using the nucleotide sugars UDP-GlcNAc 
and GDP-mannose. After transmembrane flipping, G3M9Gn2-P-P-
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mannose-P-Dol and glucose-P-Dol as donors, themselves gener-
ated with GDP-mannose and UDP-glucose (Kornfeld and Kornfeld, 
1985; Schenk et al., 2001). The precursors of nucleotide sugars are 
simple hexose phosphates. For example, mannose-6-phosphate 
(M6P) is converted by phosphomannomutase to mannose-1-P (M1P), 
which is then reacted with GTP to form GDP-mannose.
The congenital disorders of glycosylation (CDG) are recessive hu-
man genetic diseases diagnosed by underglycosylation of serum 
glycoproteins, and likely involve aberrant N-glycosylation in most 
tissues (Jaeken and Matthijs, 2001; Marquardt and Freeze, 2001). 
CDG patients generally present with developmental, neurological, 
and metabolic abnormalities during early childhood, often with poor 
survival. CDG type Ia, by far the most commonly diagnosed form of 
CDG, is caused by mutations affecting the PMM2 gene encoding 
phosphomannomutase. The disease is thought to result from insuf-
ficient formation of M1P by this enzyme, with compromised produc-
tion of GDP-mannose for LLOs and other mannosylated glycoconju-
gates. However, it is also possible that dysfunctional PMM2 results in 
accumulation of M6P, the enzyme’s substrate, which is in some way 
detrimental to the LLO pool. This concept is supported by work us-
ing a defined system for LLO biosynthesis, where addition of 50 µM 
M6P caused specific degradation of G3M9Gn2-P-P-Dol in a variety 
of streptolysin-O (SLO)-permeabilized mammalian cells (dermal fi-
broblasts, CHO-K1 cells, and primary hepatocytes), and release of 
free G3M9Gn2 (Gao et al., 2005; Figure 1, right, inset). In this system, 
LLO intermediates smaller than G3M9Gn2-P-P-Dol were not sensi-
tive to M6P-dependent cleavage, and structurally related M6P ana-
logues, including glucose-6-P (G6P) and M1P were ineffective. 
These findings strongly suggest that M6P modulates a discrete tar-
get in the LLO pathway to cause G3M9Gn2-P-P-Dol degradation.
Though highly specific in nature, the context and purpose of the 
M6P-dependent LLO cleavage detected in permeabilized cells re-
mains unknown. We previously reported how one stress-signaling 
pathway can balance LLO flux with client polypeptide load (Shang 
et al., 2007; Figure 1). In this paper, we report that M6P-dependent 
G3M9Gn2-P-P-Dol degradation represents the terminus of a second, 
unique, stress-activated pathway in intact cells, in which M6P be-
haves as a signaling molecule for regulated LLO destruction. This 
result prompted us to reassess LLO fate in the context of viral infec-
tion, a well-known paradigm for N-glycosylation. In particular, 
we find that ER stress, M6P production, and LLO destruction are 
triggered by infection with the N-glycosylated pathogen herpes 
simplex virus 1 (HSV-1), suggesting a potential host-defense mecha-
nism. We speculate that the etiology of CDG-Ia, in which M6P 
accumulation is predicted, may involve this mechanism having gone 
awry.
FIGURE 1: ER stress reduces LLO consumption due to N-glycosylation. In response to ER stress, PERK is activated to 
phosphorylate eIF2α, attenuating translation. This diminishes nascent polypeptide chains inside the ER lumen. As many 
of these polypeptides are acceptors for OT, this also lowers consumption of mature LLOs, functionally coupling LLO flux 
to glycoprotein synthesis (Shang et al., 2007). Dol-P-P (facing the lumen) released during LLO consumption is recycled 
to Dol-P, which faces the cytosol (dolichols are indicated by black rectangles). Cytosolically oriented Dol-P serves as the 
carrier for assembly of a seven-sugar glycan intermediate coupled by a pyrophosphate linkage. After transmembrane 
flipping, extension to a 14-sugar glycan results in formation of mature LLO. The 14-sugar glycan is presented at the 
upper left, with the dashed line showing the seven-sugar intermediate. The inset at the upper right illustrates a reaction 
identified with permeabilized mammalian cells, in which cytosolic M6P causes cleavage of mature LLO and generation of 
a free 14-sugar glycan. Presumably, M6P activates a catalytic ER membrane component (Gao et al., 2005).
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RESULTS
Initial evidence for regulated LLO destruction in intact 
cells—generation of Dol-P by ER stress
Transfer of the 14-sugar G3M9Gn2 glycan from LLO to nascent ER 
polypeptide yields Dol-P-P as a byproduct, which is efficiently recy-
cled to Dol-P to seed a new round of LLO synthesis (Schenk et al., 
2001; Figure 1). As shown by others (Spiro et al., 1976; Schmitt and 
Elbein, 1979; Hubbard and Robbins, 1980; Grant and Lennarz, 1983) 
and reproduced by us (Gao and Lehrman, 2002b), this “dolichol cy-
cle” is interrupted by inhibitors of protein synthesis such as cyclohex-
imide (CHX), which traps the Dol-P in LLO molecules. It therefore 
seemed reasonable that physiological stimuli that slow translation 
would also hinder the dolichol cycle and diminish Dol-P availability. 
One such translation-attenuating activity is mediated by the ER-asso-
ciated transmembrane kinase “PKR-like ER kinase” (PERK, also known 
as PEK [Sood et al., 2000]). PERK has a lumenal stress-sensing do-
main and a cytosolic Ser/Thr kinase domain. In response to ER stress, 
PERK phosphorylates the translation initiation factor eIF2α, which re-
sults in attenuated translation initiation for ER client polypeptides 
(Figure 1). Thus, we devised experiments to test the hypothesis that 
PERK activation would trap a large portion of the Dol-P pool as LLO.
Dol-P levels in normal mouse embryonic fibroblasts (MEFs) with 
functional PERK were consequently evaluated after treatment with 
either of two well-known ER stressors: dithiothreitol (DTT), which re-
duces disulfide bonds of ER proteins; and thapsigargin (TG), which 
blocks ER calcium channel ATPase activity, resulting in calcium loss. 
As for the M6P-dependent reaction discussed in the Introduction, 
proper measurement of Dol-P in the dolichol cycle requires reten-
tion of fragile ER structure by gentle permeabilization with SLO. This 
procedure is unlike those employing homogenization and isolation 
of microsomal membranes, which obscure this pool of Dol-P (Gao 
and Lehrman, 2002b). Thus, SLO treatment permits reliable study of 
the dolichol cycle with radioactive nucleotide sugar donors for Dol-
P-dependent enzymes. Figure 2A presents the reactions and re-
agents used in this analysis.
In the first step of LLO formation, UDP-GlcNAc donates GlcNAc-
1-P for Dol-P-dependent synthesis of GlcNAc-P-P-Dol (Lehrman, 
1991). Treatment with a three–amino acid OT acceptor peptide (AP), 
resulting in transfer of the LLO-associated glycan to the peptide and 
generation of Dol-P, increased GlcNAc-P-P-Dol synthesis in PERK+/+ 
samples to ∼260% of control levels (Figure 2B). Although PERK-
dependent translation attenuation was expected to strongly 
FIGURE 2: ER stress causes release of Dol-P from a preexisting LLO pool. (A) Influences of ER stressors and other 
factors on the dolichol cycle, and assay of Dol-P with nucleotide-[3H]sugars. Reactions in black occur in intact cells, and 
those in gray are in SLO-permeabilized cells. G3M9Gn2-P-P-Dol is consumed by transfer of glycan to protein, water 
(hydrolysis), or OT AP; Dol-P is regenerated in all cases. (B) PERK+/+ and (C–E) PERK−/− MEFs were left untreated (–) or 
treated for 1 h with 2 mM DTT, 150 nM TG, or 200 μM CHX, as indicated. After permeabilization with SLO, they were 
incubated with either UDP-[3H]GlcNAc (B, C, and E) or GDP-[3H]mannose (D); this procedure assays the limited pool of 
Dol-P restricted to the dolichol cycle (Gao and Lehrman, 2002b). Some incubations contained 50 μM (B–D) or variable (E) 
concentrations of a control tripeptide (CP) unable to serve as OT substrate, or AP. Condition labels under (D) also apply 
to (B and C). [3H]lipids were determined by liquid scintillation spectroscopy. Bars are labeled with percent activities and 
are the averages of duplicates. The highest ranges among duplicates were ± 5, 6, 19, and 10%, for (B–E), respectively.
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decrease GlcNAc-P-P-Dol synthesis by depleting Dol-P, only a mild 
loss of GlcNAc-P-P-Dol was measured with DTT (∼60% of control 
levels). More surprisingly, an increase (∼160% of control levels) in 
activity was detected with TG. Together, these data suggested that 
two opposing effects were in play: the anticipated suppression of 
Dol-P levels by ER stress due to PERK-dependent translation attenu-
ation (Figure 1), and offsetting production of Dol-P by an unknown 
effect of ER stress. Testing this hypothesis with PERK−/− MEFs 
(Figure 2C) revealed that treatments with DTT or TG each substan-
tially increased Dol-P (∼250% of unstressed controls). This repre-
sented a large fraction of the Dol-P in PERK−/− MEFs that could be 
released from LLO by discharge with AP (∼370% of controls). When 
mixed, the effects of DTT and AP were not additive, suggesting they 
acted upon the same pools of LLO and Dol-P (Figure 2, C–D), and 
DTT was not behaving as a nonspecific enzyme stimulator.
These results with PERK−/− MEFs were not limited to the GlcNAc-
1-P transferase itself, because similar effects were detected with 
GDP-mannose used to evaluate Dol-P-dependent mannose-P-
dolichol synthesis (product was increased to ∼180% of unstressed 
controls by ER stress [Figure 2D]). In sharp contrast to ER stressors, 
CHX reduced GlcNAc-P-P-Dol synthesis to ∼45% of unstressed con-
trols, demonstrating that the dolichol cycle had the expected sensi-
tivity to translation rate (Figure 2E). The ability of CHX to trap Dol-P 
as LLO was countered by acceptor peptide, which released the 
trapped Dol-P. As in Figure 2C, the effects of the DTT and AP treat-
ments shown in Figure 2E were not additive.
Since DTT could not supplement the effects of AP, ER stress 
did not appear to cause new Dol-P synthesis. Rather, the results 
were best explained by ER stress liberating Dol-P from pre-
formed LLO, as did AP, by cleavage within the pyrophosphate 
linkage (accompanied if necessary by either pyrophosphatase 
or dolichol kinase action [Schenk et al., 2001]). As shown in 
Figure 2B, active PERK obscured this observation. Consequently, 
for clarity, most of our subsequent biochemical analysis of this 
unexpected LLO degradation was performed with PERK−/− 
MEFs, although key results were repeated with PERK+/+ MEFs.
ER stress increases M6P and decreases steady-state LLO 
levels
No signaling pathways are known that explain LLO cleavage and 
Dol-P generation in ER-stressed MEFs indicated in the schematic 
in Figure 2. As reviewed in the Introduction, we previously dem-
onstrated that M6P can stimulate release of free glycans from 
LLO in permeabilized cells (Figure 1, inset), and therefore specu-
lated this mechanism might be utilized by cells under the type of 
ER stress induced by DTT and TG. This hypothesis makes several 
testable predictions: 1) ER stress should elevate M6P to concen-
trations sufficient to induce LLO cleavage; 2) elevated M6P levels 
caused by ER stress should decrease LLOs and increase the prod-
ucts of their cleavage—namely Dol-P (Figure 2) and free glycans; 
and 3) the process should be regulated by an authentic ER stress–
sensing molecule. We thus set about testing these predictions 
systematically, beginning with an assessment of M6P responsive-
ness and levels in MEFs.
We used fluorophore-assisted carbohydrate electrophoresis 
(FACE) as a general method for profiling steady-state levels of intra-
cellular saccharides and associated molecules (e.g., LLOs). FACE 
takes advantage of fluorophore conjugation to carbohydrates, with 
differing purification schemes and fluorophore reactivities useful in 
profiling different carbohydrate species. FACE also has the advan-
tage of not requiring glucose deprivation of cells, which is often 
used during metabolic labeling studies and which is capable of per-
turbing ER function and saccharide analysis (Gao and Lehrman, 
2002a; Lehrman, 2007). Using FACE, we first asked whether M6P 
specifically stimulated release of G3M9Gn2 in SLO-treated MEFs, a 
permeabilized cell type that had not been previously evaluated for 
this reaction.
As shown in Figure 3A, 50 µM M6P, but not G6P, promoted 
G3M9Gn2 release from LLO in SLO-permeabilized MEFs, indicat-
ing these cells contained the components needed to respond to 
M6P. We previously reported that several hexose-Ps in mammalian 
cells were mobilized by ER stress, presumably to aid glycoconju-
gate synthesis and ATP production (Doerrler and Lehrman, 1999; 
FIGURE 3: ER stress elevates M6P. (A) SLO-permeabilized normal (MPI+/+) MEFs were incubated 1 h at 37°C with 
nucleotide sugar LLO precursors in the absence or presence of 100 μM G6P, 100 μM M6P, and/or 200 μM M6Po. 
Released free glycans (G4–G7 equivalent pool) measured by FACE are expressed as percent of untreated controls 
(duplicates ± range). (B) FACE gels showing hexose-Ps of PERK+/+ and PERK−/− MEFs, either unstressed (triplicates) or 
stressed (2 mM DTT [triplicates] or 150 nM TG [duplicates]) for 1 h. Cells were ∼80% confluent. Electrophoresis is top to 
bottom. Positions of AMAC-conjugated standards are labeled. When required, G1P-AMAC and M1P-AMAC were 
resolved by running gels longer (e.g., see Figure 6B, upper). Although labeled as hexose-1-Ps for clarity, FACE analysis 
requires dephosphorylation of M1P and G1P prior to AMAC conjugation. Cross-hatched bars indicate unidentified 
AMAC conjugates increased by ER stress. (C) Intracellular M6P concentrations (μM) in PERK−/− MEFs (averages of 
duplicates ± range) after no treatment (white) or treatments with DTT (2 mM, 1 h, black), TG (150 nM, 1 h, gray), or 
d-mannose (10 mM, 1 h, vertical stripes).
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Gill et al., 2002). To determine specifically whether M6P increased 
in ER-stressed MEFs, we coupled cellular pools of hexose-Ps to 
the FACE fluorophore 2-aminoacridone (AMAC). As shown in 
Figure 3B, glucose-1-P (G1P), G6P, fructose-6-P (F6P), and M6P 
(as well as several unidentified species) were all increased by 
DTT and TG. When corrected for cellular volume, M6P concentra-
tions in PERK−/− MEFs increased about fourfold, from 60 µM to 
250 µM (Figure 3C). Notably, G1P is a direct product and the other 
hexose-Ps are indirect products of glycogen breakdown by glyco-
gen phosphorylase (GP).
These data showed that MEFs contain the M6P-responsive 
component(s) needed for LLO cleavage, and that ER stress can 
increase M6P in intact MEFs in the required concentration range. 
To directly assess whether the elevated M6P might have caused 
LLO cleavage, and therefore provide an explanation for the 
generation of Dol-P (Figures 2 and 4A) in intact stressed MEFs, we 
used a variation of the FACE technique in which the glycan por-
tions of LLOs were released from the lipid carrier with mild acid, 
and then labeled with the fluorophore 7-amino-1,3-naphthalene-
disulfonic acid (ANDS; Gao and Lehrman, 2006; Lehrman, 2007). 
Interestingly, both DTT and TG stresses resulted in a statistically 
significant suppression of G3M9Gn2-P-P-Dol levels in PERK−/− 
MEFs (Figure 4B). No truncated LLOs were generated (Figure 4C). 
Thus, there was no degradation within the LLO glycan moiety, 
further supporting the hypothesis that ER stress activated LLO 
cleavage within the pyrophosphate linkage.
ER stress causes the appearance of LLO-derived  
free glycans
Using FACE, we next measured levels of free glycans predicted by 
hydrolysis of G3M9Gn2-P-P-Dol (Figure 4A). Conjugation of the 
ANDS fluorophore requires a reducing end on the oligosaccharide, 
which could result from cleavage between the reducing terminal 
GlcNAc and the pyrophosphate linkage, or cleavage within the py-
rophosphate linkage followed by dephosphorylation of the result-
ing phospho-oligosaccharide. After DTT or TG treatments, free gly-
can pools in PERK−/− MEFs were altered significantly (Figure 5A) 
with an approximately twofold increase of the total pool (presented 
below in Figure 6). Although G3M9Gn2 itself was not apparent in 
free glycan pools, it could be preserved by inclusion of the glucosi-
dase inhibitor castanospermine (Figure S1), consistent with rapid 
digestion by intracellular glycosidases. However, castanospermine 
was not used routinely in our experiments because it causes ER 
stress (Doerrler and Lehrman, 1999).
Significantly, free glycans released by ER stress were sensitive to 
diagnostic enzymatic digestions for LLO-type structures. Glycans 
that migrated more slowly than the G6 standard (Figure 5B), in the 
range expected for M6Gn2 to G3M9Gn2, were susceptible to endo-
glycosidase H—an enzyme that senses the presence of a specific 
α1,3-linked mannosyl residue on mature LLOs and many of the 
larger LLO intermediates. Moreover, all of the glycans were sensitive 
to jack bean α-mannosidase. This enzyme cleaves exposed α-linked 
mannosyl residues expected on LLO-derived glycans. The observa-
tion of a resistant fragment in the G5–G6 range is consistent with the 
presence of blocking glucosyl residues, which are also a feature of 
some LLO-derived glycans. Tunicamycin (TN), an inhibitor of LLO 
synthesis as well as an inducer of ER stress, did not increase free 
glycans (Figure 5A).
These data were highly consistent with destruction of LLO by ER 
stress, yielding Dol-P and free glycans (Figure 4A). However, a pos-
sibility remained that the free glycan increases were actually caused 
by ERAD of nascent glycoproteins destabilized by ER stressors 
(Figure 5C). This could be especially severe in PERK−/− MEFs, which 
are unable to limit new glycoprotein synthesis in response to ER 
stress. To distinguish between LLO cleavage and ERAD, we ana-
lyzed the subcellular compartmentalization of the free glycans. 
Glycans increased by ERAD should be cytosolic, while LLO-derived 
glycans should be lumenal (Chantret and Moore, 2008). These pop-
ulations can be distinguished as retained (lumenal) and diffusible 
(cytosolic) glycan pools after permeabilization with SLO (Moore 
et al., 1995; Figure 5C).
As expected, the two types of free glycan pools in MEFs were 
distinctly different (Figure 5D). Significantly, both DTT and TG in-
creased lumenal free glycan pools, while there were no effects on 
FIGURE 4: LLO destruction in ER-stressed MEFs. (A) LLO cleavage is 
expected to elevate levels of Dol-P/Dol-P-P and lumenal free glycans, 
the latter digested by lumenal glycosidases. (B) FACE measurements of 
G3M9Gn2-P-P-Dol for DTT- (black) or TG- (gray) treated PERK+/+ and 
PERK−/− MEFs, expressed as percentages for untreated (white) cells 
(mean ± SEM; n = 4 and 6, respectively; *, p < 0.0001 compared with 
unstressed control). (C) FACE gels of LLOs from PERK+/+ and PERK−/− 
MEFs after treatment with DTT or TN (5 μg/ml, 1 h) show that ER stress 
does not degrade the glycan component. Standards are indicated.
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cytosolic pools. This showed that ER stress 
caused LLO cleavage, but without a free 
glycan contribution by ERAD. Further, 
z-VAK-fmk (an inhibitor of cytosolic N-glyca-
nase [Misaghi et al., 2004]), did not prevent 
the ER stress–dependent increase of free 
glycans. Experiments presented in the next 
section with inhibitors of glycogen phos-
phorylase also address ERAD.
In summary, ER stress–induced in-
creases of M6P in intact cells correspond 
with loss of G3M9Gn2-P-P-Dol and appear-
ance of LLO-derived Dol-P and lumenal 
free glycans. While fastidious LLO biosyn-
thesis is critical for proper N-linked glyco-
sylation, our results suggested M6P might 
have a paradoxical function in impeding 
LLO usage. The experiments that follow, 
which were intended to further elucidate 
M6P’s role, evaluated the metabolic origin 
of M6P, its necessity for LLO cleavage, and 
its signaling pathway.
ER stress–dependent M6P originates 
from glycogen  
and is necessary for LLO cleavage
We considered hypotheses for both intrac-
ellular and extracellular sources of the ER 
stress–generated hexose-Ps. Since ER stress 
does not appear to stimulate hexose trans-
port or hexokinase activities (Doerrler and 
Lehrman, 1999; Gill et al., 2002), it was un-
likely that intracellular hexose-Ps were in-
creased by these mechanisms. In contrast, 
ER stress did correlate with decreased gly-
cogen content (Gill et al., 2002), and it also 
correlated with increases in metabolites of 
glycogenolysis (Figures 3B and 6A), sug-
gesting that glycogen may be an intracellu-
lar source of these sugars.
The hypothesis that ER stress triggered 
glycogenolysis was tested by treating ER-
stressed MEFs with a highly efficacious in-
hibitor of GP, the indole-2-carboxamide 
CP-91149 (Figure 6A; Martin et al., 1998). 
As shown in Figure 6B, CP-91149 effi-
ciently blocked the appearance of all 
DTT- and TG-inducible G1P, the immedi-
ate product of glycogenolysis. Equally as 
important, blocking glycogenolysis with 
CP-91149 also prevented the increases of 
G6P, F6P, and M6P (Figure 6C), all of which 
can be formed from G1P (Figure 6A). To 
address the possibility that a nonglycogen 
source of sugars was blocked by an un-
expected off-target activity of CP-91149, 
we evaluated two additional GP inhibitors 
having different mechanisms than 
CP91149. While CP-91149 interacts with a 
novel GP site (Oikonomakos et al., 2000; 
Rath et al., 2000), caffeine inhibits the known 
purine-binding site (Johnson, 1992), and 
FIGURE 5: ER stress generates LLO-derived lumenal free glycans. (A) Free glycans in PERK−/− 
MEFs after treatments with DTT, TG, or TN. The positions of M5Gn2 and G3M9Gn2 standards 
on FACE gels are shown. (B) PERK−/− MEFs were left untreated, or treated 1 h with either 
2 mM DTT or 150 nM TG. ANDS-conjugated free glycans were incubated in the absence or 
presence of endoglycosidase H or α-mannosidase. Note that Gn1-ANDS generated by 
endoglycosidase H runs off the gel. (C) Free glycans released from LLOs in response to M6P 
are predicted to be in the ER lumen. In contrast, free glycans from protein misfolding, export 
from the lumen, and enzymatic deglycosylation during ERAD should be cytosolic. In both 
pathways, glycans can be digested by various exoglycosidases (indicated by the repeating 
arrows) to generate heterogeneous structures. The lumenal and cytosolic glycan pools can be 
distinguished by SLO permeabilization. See Figure 1 for explanation of symbols. (D) After 
treatment of PERK−/− MEFs with DTT or TG, free glycans were analyzed directly from whole 
cells (Total), or after permeabilization with SLO, to yield lumenal free glycans (Lum.) in cell 
bodies and cytosolic free glycans (Cyto.) in permeabilization medium. In this and similar 
experiments, we noticed that the Total signals appear greater than the sums of the lumenal 
plus cytosolic signals, presumably due to sample loss occurring during the additional SLO 
step. (E) PERK+/+ MEFs, as for (A).
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1,4-dideoxy-1,4-imino-d-arabinitol (DAB) targets the catalytic site 
(Oikonomakos et al., 2006). Like CP-91149, these two GP inhibi-
tors impaired DTT- and TG-dependent hexose-P mobilization (un-
published data). From these experiments and earlier results (Gill 
et al., 2002), we conclude that glycogen is the source of ER stress–
dependent hexose-Ps.
If LLO cleavage is caused by M6P produced via ER stress–depen-
dent glycogenolysis, then GP inhibitors should prevent the formation 
of LLO-derived free glycans. As shown in Figure 6D, this was indeed 
the case: CP-91149, caffeine, and DAB each hindered DTT- and TG-
dependent free glycan increases. These results also further ruled out 
a contribution by ERAD (which should have been insensitive to these 
inhibitors), as well as LLO cleavage by a nonspecific effect of ER 
stress on the labile pyrophosphate bond. Collectively, these results 
link ER stress to glycogenolysis, elevated M6P, and LLO cleavage.
M6P introduced in the absence of ER stress is sufficient  
to cause LLO cleavage
To test the sufficiency of M6P for LLO cleavage by an independent 
method, we introduced it into cells at appropriate concentrations, 
but in the absence of ER stress. As shown in Figures 7, A–C, a 
60-min incubation of PERK−/− MEFs in medium supplemented with 
10 mM d-mannose increased intracellular M6P by three- to sixfold, 
to ∼180 µM (Figure 3C). Using analyses similar to those described 
in the preceding sections for ER-stressed cells, we found that these 
conditions stimulated LLO cleavage: G3M9Gn2-P-P-Dol decreased 
to 82 ± 2% (n = 2) of untreated levels, and significantly, lumenal free 
glycans increased (Figures 7, A–D). There was no effect of incuba-
tion with 10 mM d-galactose, the 2- and 4-epimer of d-mannose. 
LLO cleavage was therefore not explained by nonspecific osmotic 
factors.
FIGURE 6: Glycogen phosphorylase inhibitors block ER stress–induced hexose-P mobilization and free glycan increases. 
(A) Scheme linking glycogenolysis and extracellular mannose to hexose-Ps and GDP-mannose. Three GP inhibitors are 
indicated. Determinations of (B) hexose-1-Ps, (C) hexose-6-Ps, and (D) free glycans. Where indicated, PERK−/− MEFs 
were either left unstressed (white bars) or stressed with 2 mM DTT (black) or 150 nM TG (gray) for 1 h prior to 
saccharide harvest, in the absence or presence of 50–100 μM CP-91149, 5 mM caffeine, or 20 μM DAB (each for 2 h 
prior to saccharide harvest). Each panel includes one representative FACE gel (upper) and averaged data from four 
independent FACE experiments (lower), measuring total pools of hexose-Ps or the G4–G7 equivalent pool of free 
glycans. , p < 0.001 for all inhibitor-free stressed samples compared with inhibitor-free unstressed controls. *, p < 0.001; 
#, p < 0.005; ∇, p < 0.01; +, p < 0.08 for inhibitor-treated stressed samples compared with inhibitor-free stressed 
samples.
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Mannose treatment itself did not cause ER stress, because stress-
associated hexose-6-Ps other than M6P (i.e., G6P and F6P) were not 
elevated (Figure 7, A and C). Mannose treatment of MEFs did not 
increase GRP78/BiP mRNA, and neither brief nor extended man-
nose treatments increased splicing of XBP1 mRNA (Figure S2), both 
sensitive markers for ER stress signaling. Mannose treatment gener-
ated free glycans even during CHX treatment, to prevent synthesis 
of newly synthesized glycoproteins, which might be ERAD sub-
strates and hence glycan sources (unpublished data). Therefore, 
we find no evidence that the free glycans generated by mannose 
treatment were due to inadvertent ER stress or ERAD.
As seen in Figure 7A, 10 mM mannose treatment increased both 
M6P and M1P. However, M1P was not increased by ER stress, and 
none of the other ER stress-induced metabolites of glycogenolysis 
(G1P, G6P, and F6P) were increased by mannose treatment. Thus 
M6P was the only hexose-P increased under all conditions causing 
LLO cleavage. It is unclear why elevated M6P appeared to drive 
formation of M1P (a single enzymatic step; Figure 6A) after mannose 
incubation; but not with ER stress; perhaps ER stress also promotes 
reactions that consume M1P. Coupled with 
the strong specificity for M6P in permeabi-
lized cell experiments (Figure 3A; Gao et al., 
2005), we conclude that increased M6P is 
sufficient to drive LLO cleavage in intact 
cells, even in the absence of ER stress.
Inhibition by a structural analogue 
reveals a defined  
M6P target
Taken together, our data surprisingly impli-
cate M6P as a signaling molecule. As such, 
it would be predicted to have a defined tar-
get, and be regulated by other signaling 
components. To understand these biologi-
cal properties in greater detail, we adopted 
two approaches. First, we probed for the 
presence of an M6P interaction site in LLO 
cleavage reactions. Second, we sought to 
identify the signal transducer that triggers 
glycogenolysis (and hence M6P production) 
in response to ER stress. Some aspects of 
the M6P interaction site could already be 
deduced by our earlier permeabilized-cell 
experiments. Our findings that both M1P 
and G6P (the 2-epimer of M6P) failed to 
promote LLO cleavage suggested that the 
orientation of the 2-hydroxyl and the posi-
tion of the phosphate in M6P are important 
for the M6P interaction and M6P-dependent 
signaling.
To further explore the requirements for 
M6P’s interaction with a target site, we syn-
thesized the nonhydrolyzable analogue 
mannose-6-phosphonate (M6Po; Figure 
S3A; compound 11 in Belakhov et al. [2004]). 
The M6Po preparation was free of detect-
able contaminating M6P (Figure S3B), and 
M6Po alone did not cause LLO cleavage 
with SLO-permeabilized cells (Figure S3C). 
However, inclusion of M6Po partially inhib-
ited LLO cleavage caused by M6P, while 
inclusion of G6P or M1P had no effect 
(Figures 3A and S3D). The esterifying oxygen atom of M6P is there-
fore important for LLO cleavage, but not for binding to the M6P 
target site, allowing M6Po to antagonize M6P. It remains to be de-
termined whether the esterifying oxygen mediates an activation 
step at the target site, and/or is involved in a requirement for M6P 
hydrolysis.
Authentic UPR signaling mobilizes hexose phosphates
To identify signaling components that might regulate M6P, we fo-
cused upon the abilities of DTT and TG to promote glycogenoly-
sis, and considered two possibilities. First, as known ER stressors, 
DTT and TG might have triggered the unfolded protein response 
(UPR), an elaborate set of signaling events that occur in response 
to the presence of excess misfolded protein in the ER lumen 
(Schröder and Kaufman, 2005; Ron and Walter, 2007; Figure 8A). 
Alternatively, these agents may have unexpectedly altered hexose 
metabolic pathways by their effects on redox potential and cal-
cium homeostasis. If the UPR was involved, hexose-P mobilization 
should be diminished by stable overexpression of GRP78/BiP 
FIGURE 7: Elevation of M6P in the absence of ER stress releases free glycans. (A–D) PERK−/− 
MEFs were incubated with (A, B) variable concentrations of mannose for 60 min; (C) 10 mM 
mannose for variable times; or (D) 10 mM mannose for 60 min. (A and C) Hexose-Ps (top) and 
free glycans (bottom) as in Figures 3B, 5A, and 6B. Black arrowheads indicate glycans increased 
by mannose treatment. (B) Quantitative measurements (averages of duplicates) of M6P (white) 
and total free glycans migrating in the G4–G7 standard range (black) from (A). (D) Lumenal and 
cytosolic free glycans from untreated or mannose-treated cells were separated, as in Figure 5D. 
Standard lanes are marked with asterisks. (E) As for (C), with PERK+/+ MEFs.
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(Dorner et al., 1992) to counteract dissociation of this chaperone 
from lumenal stress-sensing domains of UPR-signaling proteins 
and attenuate their activities (Figure 8A).
As shown in Figure S4A, overexpression of GRP78/BiP caused 
the expected reduction of UPR-dependent XBP1 splicing by either 
DTT or TG. Since the GRP78/BiP overexpressing cells were derived 
from tumor-like CHO-K1 cells, they were expected to have enhanced 
glycolysis (Levine and Puzio-Kuter, 2010), which could complicate 
hexose-P analysis; most of the F6P from glycogenolysis would likely 
be catabolized for ATP production, leaving little for conversion to 
M6P. We therefore focused on G6P, the intermediate preceding F6P, 
as an alternative readout for glycogenolysis (Figure 6A). As shown in 
Figure 8B, DTT and TG clearly elevated G6P in unmodified CHO-K1 
cells, while G6P production was suppressed by overexpressing 
GRP78/BiP. Thus, one or more UPR-signaling proteins were respon-
sible for mobilization of hexose-Ps.
Hexose-6-P mobilization is fast (detectable within 10 min of DTT 
application [Gill et al., 2002]), arguing against transcriptional control. 
This focused our attention on the UPR transmembrane kinases PERK 
and inositol-requiring enzyme 1 (IRE1), which employ rapid auto-
phosphorylation mechanisms and can be evaluated directly with 
MEF knockout lines. Knockout of PERK did not affect the abilities of 
FIGURE 8: UPR signaling by IRE1α mobilizes hexose-Ps. (A) UPR-dependent actions of chemicals that cause protein 
misfolding can be distinguished from other possible effects of these chemicals by overexpression of GRP78/BiP. Under 
normal conditions, sufficient GRP78/BiP is available to complex with the lumenal stress-sensing domains of UPR signal 
transducers such as IRE1, maintaining them in an inactive state (i). In the presence of excess misfolded protein, GRP78 is 
no longer available to complex with IRE1, resulting in its dimerization and activation (ii). However, when GRP78 is 
overexpressed, there is sufficient GRP78 to suppress IRE1 signaling, even in the presence of excess misfolded protein 
(iii). (B) Hexose-Ps in untransfected (top) and GRP78/BiP-overexpressing (bottom) CHO-K1 cells after DTT or TG 
treatments. Asterisk denotes standard lane. While the effect on G6P is robust, changes in F6P and M6P are likely muted 
due to the enhanced glycolysis expected for these cells. (C) G6P (top) and M6P (bottom) levels in ER-stressed PERK−/−, 
IRE1α−/−, and XBP1−/− knockout MEFs as percentages of untreated cells, paired with genetically unmodified (+/+) 
controls. For direct comparison, all cells were processed in a single experiment (also yielding Figure S4B), average of 
duplicates ± range. (D) Immunoblots (anti-IRE1α antibody) showing knockdown of IRE1α in normal (MPI+/+) MEFs after 
RNA interference with a pool of four anti-IRE1α siRNAs. Protein size markers are shown. The three siRNA treatments 
used to generate the averaged data in (E) are shown. (E) G6P was measured by FACE after IRE1α knockdown in 
ER-stressed normal MEFs, expressed as fold change compared with buffer (no siRNA) controls, averaging three sets of 
duplicate determinations (n = 6, mean ± SEM; *, p < 0.0002 for untreated buffer controls compared with DTT-treated 
buffer samples, and for the latter compared with DTT-treated siRNA samples). (F) Relative G6P levels in untreated and 
DTT-stressed normal MEFs after RNA interference treatment as described in (E), with buffer only, siRNA1 alone, siRNA2 
alone, or a pool of four nontargeting siRNAs (mean ± SEM, n = 3; *, p < 0.0001 for untreated buffer and nontargeting 
siRNA samples vs. corresponding DTT-treated buffer and nontargeting siRNA samples). 
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DTT or TG to mobilize G6P or M6P (Figures 3B and 8C). However, 
the response was blocked by knockout of IRE1α (Figure 8C). Three 
nucleotide sugars (UDP-GlcNAc, GDP-mannose, and UDP-glucose) 
synthesized from hexose-Ps also increased with ER stress, but also 
required IRE1α (Figure S4B). These results implicated IRE1α as an 
essential UPR component involved in glycogenolysis and hexose-P 
generation.
To independently assess the requirement for IRE1α, we used 
RNA interference. Suppression of IRE1α in normal MEFs with four 
pooled small interfering RNAs (siRNAs) caused 68–95% loss of 
IRE1α protein (Figure 8D) and inhibited hexose-P mobilization 
(Figure 8E). This result was extended with two individual siRNAs 
from the pool found most responsible for IRE1α suppression. Knock-
down with either siRNA (designated siRNA1 and siRNA2, which re-
duced IRE1α protein to 48% or 38% of the buffer control, respec-
tively) also prevented hexose-P mobilization. By comparison, a pool 
of four nontargeting siRNAs had no effect (Figure 8F). Taken to-
gether, knockout and knockdown experiments showed that IRE1α is 
necessary for hexose-P mobilization by the UPR.
Signaling by the IRE1α kinase domain triggers 
glycogenolysis
IRE1α is a single-pass transmembrane protein composed of a lume-
nal stress-sensing domain, and a cytosolic unit with a Ser/Thr kinase 
domain followed by an RNase domain. Both of the cytosolic do-
mains are catalytically functional. In metazoans, IRE1α exerts most 
of its homeostatic effects by activating transcriptional programs via 
the ability of the RNase domain to regulate splicing of mRNA en-
coding the transcription factor XBP1 (Schröder and Kaufman, 2005; 
Ron and Walter, 2007). However, hexose-P mobilization and nucle-
otide sugar increases still occurred in ER-stressed XBP1−/− MEFs, 
although the TG responses were somewhat attenuated compared 
with DTT responses for reasons which remain unclear (Figures 8C 
and S4C). The absence of a requirement for XBP1 suggested two 
potential mechanisms for increasing hexose-Ps. As shown previ-
ously, it was possible that the IRE1α RNase domain caused degra-
dation of a preexisting regulatory mRNA (Hollien and Weissman, 
2006; Hetz and Glimcher, 2009). Such a mechanism might have de-
graded an mRNA involved in limiting glycogenolysis, causing eleva-
tion of hexose-P levels. Alternatively, IRE1α might have sent a signal 
directly from its kinase domain to stimulate glycogenolysis, without 
participation by the RNase domain.
To determine whether the entire cytosolic unit (kinase plus RNase 
domains) or the isolated kinase domain of IRE1α could activate gly-
cogenolysis, we employed strategies used previously for expressing 
soluble fusions of the cytosolic units of yeast IRE (Aragon et al., 2009) 
and mammalian IRE1α (Back et al., 2006) to FKBP12-derived modules 
that bind the dimerizer AP20187 (Figure 9A). By dimerizing the fusion 
proteins, AP20187 promotes direct interaction of the attached do-
mains and consequent activation of downstream events, including 
those possibly requiring transautophosphorylation. Rather than tran-
sient transfection (Back et al., 2006), we prepared stable CHO-K1 
transfectants to avoid contributions of hexose-Ps from untransfected 
cells in transiently transfected pools (Figure 9B). Thus, as for Figure 8B, 
we limited our analysis of these CHO-K1–derived lines to G6P.
In cells expressing the empty vector, AP20187 was inert as ex-
pected. However, in cells expressing the entire IRE1α cytosolic unit 
(kinase and RNase), AP20187 increased G6P (Figure 9C). This 
showed that IRE1α signaling is sufficient to mobilize hexose-P. As 
anticipated, cells expressing the kinase-only fusion protein failed to 
stimulate XBP1 splicing with AP20187 (Figure S5A). Yet, G6P in 
these cells was mobilized within 20 min of AP20187 addition at 
levels equivalent to those achieved with DTT-induced stress 
(Figure 9C). Preliminary experiments suggest this activity requires 
kinase function, because it was abrogated by a Lys599Ala kinase-
dead mutation, although the mutant protein was stably expressed. 
The effects of IRE1α activation were transient, suggesting a process 
for disengagement of signaling; after an initial increase, we detected 
a recovery phase within 1 h (Figure 9D). To verify that glycogenolysis 
was involved, we tested the GP inhibitor CP-91149. As shown in 
Figure 9E, CP-91149 blocked the AP20187-dependent increase of 
G6P in cells expressing the AP20187-responsive kinase domain. An 
extensive analysis of potential off-target effects of CP-91149 
and AP20187 on reactions relevant to this study was performed 
(Figures S5B–F). Although some unanticipated effects of CP-91149 
were identified, they did not affect the final outcomes of the experi-
ments reported here. Moreover, there was no unexpected interfer-
ence between CP-91149 and AP20187.
In summary, UPR signaling involving the IRE1α kinase domain 
activates glycogenolysis to elevate hexose-Ps. This allows IRE1α to 
regulate the ability of M6P to cause LLO destruction.
PERK stabilizes LLO pools despite ongoing LLO destruction
In general, the UPR plays an important role in maintaining ER 
homeostasis. Along these lines, the UPR can aid LLO assembly 
(Lehrman, 2006). One mechanism involves a role for PERK in balanc-
ing translation rates to compensate when LLO flux is impaired 
(Shang et al., 2007; Figure 1). Additionally, since ER stress increased 
hexose-Ps, which are precursors of UDP-GlcNAc, GDP-mannose, 
and UDP-glucose, the nucleotide sugar building blocks for LLOs, we 
measured these molecules directly. As shown in Figure S4B, all three 
nucleotide sugars were increased by the UPR in an IRE1α-dependent 
manner, suggesting yet another mechanism by which the UPR may 
assist LLO assembly. LLO destruction by the UPR therefore presents 
a serious paradox. To address this problem, we hypothesized that 
suppression of LLO levels by a destructive mechanism in normal 
cells under conventional ER stress might be compensated by PERK, 
which can reduce LLO consumption by limiting N-glycoprotein syn-
thesis (Figure 1).
Like PERK−/− MEFs, PERK+/+ MEFs underwent LLO destruction in 
response to ER stress. Hexose-Ps, including M6P, were elevated 
(Figures 3B and 8C) and free glycans, resulting from LLO cleavage, 
were formed (Figure 5E). The other LLO cleavage product, Dol-P, 
appeared to be generated as well, although PERK’s translation-at-
tenuating activity predictably reduced the amount of Dol-P detected 
(Figures 2B,C). Free glycan formation in PERK+/+ MEFs was also re-
sponsive to mannose treatment (Figure 7E). However, steady-state 
G3M9Gn2-P-P-Dol levels were unaffected by either DTT or TG stress 
in PERK+/+ MEFs (Figure 4B). In comparison, these stressors de-
creased LLO levels in PERK−/− MEFs by ∼50%. This was attributable 
solely to differences in translation rate, because LLO levels in DTT-
stressed PERK−/− MEFs were returned to normal by pharmacologi-
cal rescue with the translation inhibitor CHX (Figure 10A).
These results demonstrate that translation attenuation by ER 
stress–activated PERK can ameliorate the effect of LLO destruction 
by stabilizing steady-state G3M9Gn2-P-P-Dol levels. In this respect, 
the outcome of IRE1α/M6P signaling is antagonized by PERK. 
IRE1α/M6P signaling and LLO destruction themselves, however, are 
independent of PERK.
M6P signaling, LLO destruction, and LLO depletion during a 
pathogenic challenge with HSV-1
Since LLO destruction appeared benign in normal PERK-expressing 
cells under conventional ER stress with DTT or TG, we hypothesized 
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that a biological context for LLO destruction might involve an ab-
normal condition, where loss of LLOs could be advantageous. One 
such condition could be infection with a pathogen required to syn-
thesize N-glycosylated components, a conjecture we chose to test 
with HSV-1, because this virus contains a number of envelope N-
glycoproteins (Compton and Courtney, 1984, 1985). In addition, vi-
rally infected mammalian cells can attenuate translation to hinder 
synthesis of viral polypeptides and to initiate autophagy/xenophagy 
(Tallóczy et al., 2002, 2006; Orvedahl et al., 2007), but HSV-1 has 
developed countermeasures to prevent translation attenuation, 
including that dependent upon PERK (Mulvey et al., 2007). This in-
creased the likelihood that any LLO destruction induced by HSV-
1–associated ER stress might also suppress LLO levels, as we 
observed in PERK knockout cells stressed with DTT and TG 
(Figures 4B and 10A).
Normal MEFs were mock-infected, infected with HSV-1 at satu-
rating multiplicity, or TG-treated. Hexose-Ps, free glycans, and LLOs 
were then harvested. Shown in Figure 10B, G6P and M6P increased 
similarly after TG treatment and 12 h postinfection (h.p.i.) with HSV-
1, which is indicative of ER stress caused by infection. LLO destruc-
tion occurred in both cases, resulting in an increased pool of quali-
tatively indistinguishable free glycans (Figure 10C). Importantly, 
normal MEFs under HSV-1–induced ER stress had LLO levels 
decreased by ∼50% (Figure 10, B and D), similar to that observed 
with PERK−/− MEFs under conventional ER stress (Figure 4B). 
There was little effect at 5 h.p.i., when synthesis of a representative 
FIGURE 9: Inducible activation of the IRE1α kinase domain signals hexose-P mobilization. (A) AP20187 was used to 
dimerize the entire cytosolic unit of IRE1α (RNase + kinase domain) or the isolated kinase domain. (B) Immunoblots 
(anti-HA antibody) showing duplicate samples from stable CHO-K1 transfectants expressing the empty vector encoding 
FKBP12, or FKBP12 fusions with either the entire cytosolic unit or the kinase domain alone. (C) Cells were untreated 
(white bars), treated with 2 mM DTT for 1 h (black bars), or treated with 4 nM AP20187 for 20 min (hatched bars). G6P is 
expressed as fold change compared with untreated cells (mean ± SEM; *, p < 0.0001 for untreated controls compared 
with DTT-treated and AP20187-treated samples). Left, empty vector (n = 3); center, complete cytosolic unit (n = 4); right, 
kinase domain only (n = 7); (D) Time course of AP20187 treatment of empty vector (white symbols) or kinase domain 
only (black symbols) transfectants showing relative G6P expressed as fold increase compared with untreated cells 
(0 min). A 2 mM DTT, 60-min result in the same experiment is also shown. Points are averages of duplicates ± range. 
(E) G6P in “kinase domain only” transfectants, as in (C) after no treatment or treatments with 4 nM AP20187 for 20 min 
and/or 50 μM CP-91149 for 2 h (mean ± SEM; n = 12; *, p < 0.0001 for untreated controls compared with AP20187-
treated samples, and for the latter compared with AP20187 + CP-91149-treated samples).
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creased M6P is both necessary and sufficient for LLO destruction, 
which yielded Dol-P plus lumenal free glycans to indicate cleavage 
within the pyrophosphate linkage. With conventional ER stressors 
(DTT, TG) in normal MEFs, PERK’s ability to attenuate translation 
stabilized LLO levels in spite of ongoing LLO destruction. In con-
trast, stresses that accompanied an absence of PERK function (i.e., 
in DTT/TG-treated MEFs lacking PERK, or in normal MEFs infected 
by HSV-1) not only activated this pathway, but also resulted in sig-
nificant suppression of LLO levels. These studies were initiated to 
explore a possible role of M6P in CDG-Ia, and support the notion 
that both elevated M6P and diminished M1P may contribute syner-
gistically to the etiology of this disease. This dual effect may explain 
the high frequency of its diagnosis, compared with all other forms of 
CDG. Together, our findings alter the broadly accepted paradigm 
for LLO synthesis and protein N-glycosylation to include unantici-
pated roles for regulated destruction of LLOs by M6P signaling.
Our results help explain recent results from experiments in 
which mannose metabolism was perturbed. In phosphomannose 
isomerase–deficient MEFs unable to interconvert M6P with F6P, in-
cubation with 0.5 mM mannose medium significantly increased cel-
lular M6P (Higashidani et al., 2009). Interestingly, the M6P elevation 
was associated with decreased G3M9Gn2-P-P-Dol, although Dol-P 
and free glycans were not measured. In a different approach, 
glycoprotein (gC) was barely detectable (Figure S6A), but substan-
tial effects were identified at 8–11 h.p.i. At this level of infection, 
when envelope glycoprotein synthesis was abundant, there was 
good temporal agreement between increases of M6P, increases of 
free glycans, and LLO loss (Figure 10D). To evaluate the plausibility 
of this approach for characterizing LLO destruction in the future with 
other enveloped viruses studied elsewhere, we demonstrated that 
results with HSV-1–infected MEFs prepared and analyzed in MAL’s 
laboratory (Figure 10) were also observed with methanolic suspen-
sions of HSV-1-infected MEFs prepared by IM’s laboratory and 
shipped to the MAL’s laboratory for analysis (Figure S6B). Taken to-
gether, we propose that viral infection is a biological context for 
M6P signaling and LLO destruction, possibly to suppress levels of 
LLOs required by the pathogen.
DISCUSSION
LLO destruction modifies the paradigm for protein  
N-glycosylation
The enigmatic ability of free M6P to promote cleavage of LLO mol-
ecules in permeabilized mammalian cells, reported earlier (Gao 
et al., 2005), is shown here to represent the terminus of a signaling 
pathway for regulated LLO destruction. This pathway is triggered by 
ER stress, leading to a cascade of IRE1α kinase domain activation, 
enhanced glycogenolysis, and elevated M6P concentrations 
(Figure 11). Complementary approaches demonstrated that in-
FIGURE 11: LLO destruction and depletion by M6P signaling during a 
pathogenic UPR. LLO destruction involves UPR signaling by the IRE1α 
kinase domain, and mobilization of M6P from glycogen. M6P then 
promotes LLO cleavage, yielding dolichol-P and lumenal free glycans, 
possibly by stimulating a hydrolytic activity of OT. PERK activation by 
conventional ER stress attenuates translation, and reduces LLO 
consumption for N-glycoprotein synthesis. This offsets the effect of 
the IRE1α signal for LLO destruction, which by itself is insufficient to 
suppress LLO levels. Thus, N-glycosylation of endogenous proteins 
remains balanced. In contrast, inhibition of PERK signaling to disable 
host defenses during HSV-1-induced stress removes the brake on 
N-glycoprotein synthesis, resulting in unabated LLO consumption. In 
combination with LLO destruction, this suppresses LLO levels, and 
envelope protein N-glycosylation becomes unbalanced. In this way, 
LLO destruction is not detrimental with conventional/physiological ER 
stresses, but may penalize invading pathogens for blocking 
translation-dependent host defenses.
FIGURE 10: HSV-1 infection mobilizes M6P, with destruction and 
depletion of LLOs. (A) Uninfected PERK−/− MEFs were treated with 
2 mM DTT and/or 0.2 mM CHX for 1 h, as indicated, and G3M9Gn2-P-
P-Dol was measured (n = 3, mean ± SEM). *, p < 0.0001 for untreated 
controls compared with DTT-treated samples; #, p < 0.002 for the 
latter compared with DTT + CHX-treated samples. (B) Normal 
(PERK+/+) MEFs were stressed with TG (gray) or infected with HSV-1 
(black). G6P, M6P, G3M9Gn2-P-P-Dol LLO, and free glycans in the 
G4–G7 range (F.G.) are expressed as percentages of untreated 
cells (white), average of duplicates ± range. Cells were infected at 
multiplicity of infection (moi) = 7.5 and analyzed 12 h.p.i. (C) FACE gel 
showing free glycans associated with (B). (D) PERK+/+ MEFs were 
infected as for (B). Total hexose-1-Ps (white squares), total hexose-6-
Ps (white circles), free glycans in the G4 -G7 range (black circles), and 
G3M9Gn2-P-P-Dol (black squares) are expressed as percentages of 5 h 
mock infection, averages of duplicates ± range (error bars are 
obscured by symbols).
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evolutionarily conserved response to environmental stress in multi-
ple kingdoms of life.
A new signaling role for the IRE1 kinase  
domain—exacerbation of LLO imbalance
Although RNase activity is important in most IRE1α signaling, our 
data reveal additional RNase-independent signaling by the kinase 
domain, as have other studies (Lipson et al., 2006). In particular, the 
“IREα interactome” mediates a number of scaffold activities of the 
autophosphorylated kinase domain that are important for apopto-
sis and autophagy (Hetz and Glimcher, 2009). Presently, the only 
known kinase substrate of IRE1α is itself. Our preliminary results 
suggest kinase function is required for IRE1α stimulation of glycog-
enolysis, a process clearly sensitive to phosphorylation (Johnson, 
1992). Phospho-IRE1α, or a downstream relay, might conceivably 
phosphorylate a glycogenolysis factor. Since chronic ER stress is 
associated with obesity and insulin resistance (Özcan et al., 2004), 
and glycogen metabolism is an important factor in glycemic con-
trol, our results suggest a new mode of involvement for IRE1α in 
these conditions.
At first glance, LLO destruction by conventional/physiological ER 
stress seems counterintuitive, because LLOs are required for N-gly-
cosylation. However, LLO levels were suppressed by LLO destruction 
only when PERK function was impaired, such as by PERK knockout or 
infection by HSV-1. This pathogen interferes with PERK signaling to 
impair xenophagy and maximize production of envelope proteins, 
which require LLOs. Thus HSV-1 disables the brake that would other-
wise match protein synthesis to LLO amount (Figure 1). As we 
showed previously, N-glycoprotein synthesis without this brake be-
comes unbalanced, and LLO need can outpace supply (Shang et al., 
2007). In support of this concept, envelope glycoproteins gB and gC 
in HSV-1–infected Vero and HEp-2 cells were underglycosylated 
(Compton and Courtney, 1984). In our study, gC in lysates of HSV-
1–infected MEFs was also underglycosylated (Figure S6C). We sug-
gest that LLO destruction signaled by IRE1’s kinase domain functions 
to exacerbate the LLO imbalance caused by unabated viral polypep-
tide production, resulting in suppression of LLO levels and undergly-
cosylation of viral polypeptides (Figure 11).
In this respect, LLO destruction could be an “arms race” mecha-
nism to specifically penalize pathogens that interfere with host de-
fenses involving PERK and eIF2α signaling (Tallóczy et al., 2002; 
Mulvey et al., 2007). The apparent futility of M6P causing destruc-
tion of its downstream LLO product may therefore be an advantage. 
Since it is used for synthesis of the LLO precursor GDP-mannose, 
M6P may be pathogen-proof, as pathogens with N-glycosylated 
components would suffer if they caused M6P loss. To evaluate such 
hypotheses, interference with either IRE1α or GP are unattractive 
experimental options, due to complicating pleiotropic effects. 
Rather, we envision experiments that interfere directly with LLO de-
struction, with the predicted result of more highly glycosylated virus 
populations with the potential to influence virulence and/or patho-
genesis. It would also be fruitful to screen for viruses that have de-
vised mechanisms to disable the LLO destruction reaction.
MATERIALS AND METHODS
Reagents 
We received at no cost CP-91149 from Pfizer (Groton, CT), and 
AP20187 and ARGENT vectors from Ariad Pharmaceuticals (Cam-
bridge, MA). TN, TG, DTT, CHX, 1,4-dideoxy-1,4-imino-d-arabinitol, 
caffeine, M6P, G6P, F6P, G1P, M1P, and mannose (all hexoses in 
d configuration) were from Sigma-Aldrich (St. Louis, MO). z-VAK-fmk 
was from Promega (Madison, WI). Control and acceptor tripeptides 
mannosidase Man2C1, which catabolizes free cytosolic glycans to 
mannose, was overexpressed in HeLa cells (Bernon et al., 2011). 
This maneuver also increased M6P, virtually eliminated G3M9Gn2-P-
P-Dol, and elevated free glycans having truncated LLO-type struc-
tures. Those authors concluded that the free glycans did not result 
from the type of LLO cleavage we reported with permeabilized cells 
(Gao et al., 2005), because intact LLO-type glycans were detected 
in those earlier experiments. However, as we now report, LLO gly-
cans released in ER-stressed intact cells become glycosidically de-
graded, and therefore appear consistent with glycans detected after 
Man2C1 overexpression. It still remains to be established whether 
the latter are lumenal or cytosolic.
Prior studies on saccharide metabolism in HSV-1–infected cells 
also agree well with the data presented in this paper. HSV-1 infec-
tion of human embryonic lung fibroblasts increased UDP-glucose 
(Brennan et al., 1976), similar to results in Figures S4B and S6B. In 
addition, LLO levels were suppressed ∼36% in HSV-1–infected Afri-
can green monkey kidney (Vero) cells (Compton and Courtney, 
1985), in accord with our measurements with MEFs (Figure 10, B 
and D). However, to our knowledge, this is the first study to report 
hexose-P increases during HSV-1 infection, and very little has been 
reported on this topic in virally infected cells.
M6P is a signaling molecule for an evolutionarily  
conserved process
M6P is the first small molecule reported to have a signaling role in 
the UPR, although other sugar phosphates can mediate signaling in 
unrelated pathways (Kabashima et al., 2003). In this context, M6P 
appears to be acting similar to a second messenger. Its action in-
volves amplifiable steps: M6P synthesis depends upon rapid enzy-
matic mobilization from a glycogen store, and it promotes an appar-
ently catalytic process for LLO cleavage. Antagonism by the 
analogue M6Po suggests a defined target site. We have yet to dem-
onstrate that M6P can be specifically inactivated to end signaling, a 
criterion for classical second-messenger action. However, if M6P has 
a special host-defense role in infected cells (see following section), 
it may be disadvantageous to terminate its action.
The M6P-activated enzyme remains unknown. OT is a strong 
candidate, because this enzyme naturally recognizes G3M9Gn2-P-P-
Dol, is less efficient with smaller LLO intermediates, and normally 
cleaves LLO at a slow basal rate in a process known as “transfer to 
water” (Turco et al., 1977; Kelleher et al., 2003; Gao et al., 2005). 
Unfortunately, enriched OT preparations cannot be properly evalu-
ated, because M6P-dependent LLO cleavage requires intact ER 
structure preserved by SLO-permeabilization (Gao et al., 2005). 
M6P does not penetrate the ER of hepatocytes (Arion, 1989), which 
are capable of M6P-dependent LLO cleavage (Gao et al., 2005). We 
therefore suggest that M6P might interact with an ER component 
having cytosolic elements, possibly one of the cytosolic domains of 
OT itself. Although little is known about the functions of OT’s cyto-
solic sequences, one possible regulatory role has been reported for 
the Saccharomyces cerevisiae enzyme (Chavan et al., 2003). It also 
remains to be determined whether LLO destruction could be car-
ried out specifically by one of the two functionally distinct isoforms 
of OT (Ruiz-Canada et al., 2009).
The bacterium Campylobacter jejuni, like eukaryotes, possesses 
an N-glycosylation pathway. It was recently shown that LLO destruc-
tion also occurs in this bacterium in response to hypoosmotic condi-
tions (Nothaft et al., 2009). Although the signaling pathway was not 
elucidated, release of bacterial oligosaccharides required OT activ-
ity, and was proposed to regulate periplasmic volume in response to 
osmotic changes. This suggests that LLO destruction may be an 
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free glycans migrating in the G4–G7 standard range were quantified 
as a group. For clarity, some images were adjusted with brightness 
and contrast tools in Microsoft PowerPoint 2003 (Redmond, WA), 
treating all data from a single gel identically. In some cases, irrele-
vant lanes were removed by cropping and joining. In many experi-
ments, we only compared samples loaded on the same FACE gel, 
often limiting the experiments to duplicate determinations, and we 
therefore present original FACE images and/or means ± error 
ranges. In experiments with at least three determinations, we report 
means ± SEM and also p values from two-tailed t tests determined 
with Graphpad Prism 5 software (La Jolla, CA).
SLO-permeabilized cells
For assessment of Dol-P, monolayers were permeabilized with SLO 
after the indicated treatments and incubated at 37°C for 20 min with 
2 ml transport buffer containing 0.1 µCi UDP-[3H]GlcNAc or 0.2 µCi 
GDP-[3H]mannose, and 2 mM AMP. Where indicated, 50 µM “con-
trol” (Ac-Gln-Tyr-Thr-CONH2) or “acceptor” (Ac-Asn-Tyr-Thr-CONH2) 
tripeptides for OT were included. [3H]lipids were recovered by ex-
traction with chloroform:methanol (2:1) with aqueous back-washing, 
evaporated to dryness, and measured by liquid scintillation spec-
troscopy (Gao and Lehrman, 2002b). Since our ability to achieve 
consistent permeabilization across multiple samples in a single ex-
periment was hindered by handling excessive numbers of dishes, it 
was necessary to limit most treatments to duplicates, in which case 
we report averages and variance where appropriate.
For separation of lumenal and cytosolic free glycans, cells were 
permeabilized with SLO, but glycosyltransferase substrates were 
omitted from the transport buffer. Incubations were for 4 min at 
37°C, followed by 15 min on ice.
SLO-permeabilized cells were also used for in vitro LLO cleavage 
assays with M6P (Gao et al., 2005). In addition to the indicated 
monosaccharides, the reactions (1 h 37°C) included 100 µM UDP-
GlcNAc, 200 µM UDP-glucose, and 0.2 µM GDP-mannose to gener-
ate LLOs, and 5 µg/ml each of castanospermine and deoxyman-
nojirimycin to inhibit glycosidases.
RNA interference of IRE1α in MEFs
Mouse (NM_023913) ERN1 ON-TARGETplus SMART Pool (L-
041030-00-0005) containing four siRNA duplexes targeting 
GAAAGGUGGUGCACAUCAA (siRNA1); CGUCAUUGCUCGU-
GAAUUG (siRNA2); UGAACUACUUGAGGAAUUA (siRNA3), and 
UGACGAAACUUCCCUUUAC (siRNA4) were from Dharmacon 
(Thermo Fisher Scientific, Lafayette, CO). RNA interference was car-
ried out with Lipofectamine RNAiMAX Transfection Reagent (Invitro-
gen) according to the manufacturer’s instructions, with modifica-
tions. Buffer alone or with siRNAs was mixed with ∼106 trypsinized 
MEFs in 100-mm dishes to reach 10 nM siRNA and achieve 30–40% 
confluence the next day. Cells were passaged 48 h later to 100-mm 
dishes and grown in siRNA-free media for at least 24 h to achieve 
80–90% of confluence. Cells were fed fresh medium at least 1 h 
prior to receiving additional treatments.
AP20187-responsive ARGENT constructs for IRE1α kinase 
domain only (aa 468–836) or cytosolic unit (kinase ± RNase 
domain; aa 468–977)
Two micrograms total MEF RNA was used for first-strand cDNA 
synthesis with SuperScript First-Strand Synthesis System for 
RT-PCR (#1904-018; Invitrogen). Of the cDNA, 10% was used 
to amplify IRE1α inserts with Expand High Fidelityplus PCR System 
(#03300242001; Roche, Indianapolis, IN) with the primer pairs 
(based upon Back et al. [2006] and NM_023913; SpeI sites 
for OT were designed and synthesized by SynPep (Dublin, CA) as 
previously described (Gao and Lehrman, 2002b). ANDS and AMAC 
were from Molecular Probes/Invitrogen (Carlsbad, CA), and all other 
FACE supplies were obtained as previously described (Gao and 
Lehrman, 2002a). Endoglycosidase H was from Calbiochem 
(San Diego, CA), and jack bean α-mannosidase was from Glyko/
Prozyme (Hayward, CA). SLO was from Corgenix (Broomfield, CO). 
Radiolabeled compounds were UDP-[3H]GlcNAc (36 Ci/mmol; 
DuPont, Wilmington, DE), GDP-[3H]mannose (15 Ci/mmol; American 
Radiolabeled Chemicals, St. Louis, MO), [3H]inulin (510 mCi/mmol; 
Amersham, GE Healthcare, Waukesha, WI), and [14C]urea 
(59 mCi/mmol; Amersham). Anti-HA (#2999), anti-PERK (#3192), 
anti-GAPDH (#3683), anti–phospho-eIF2α (#9721), and anti-IRE1α 
(#3294) were from Cell Signaling Technology (Danvers, MA). Anti–
HSV-1 gC (#NB110-57251) was from Novus Biologicals (Littleton, 
CO). Antitubulin was a gift of Melanie Cobb (University of Texas 
Southwestern Medical Center at Dallas).
Cell cultures 
Cell culture media were from Invitrogen and sera were from Atlanta 
Biologicals (Norcross, GA). CHO-K1 (Camp et al., 1993), GRP78/
BiP-overexpressing CHO-K1 transfectants (Dorner et al., 1992), and 
Fv2E-PERK-expressing CHO-K1 transfectants (Lu et al., 2004) were 
grown in Ham’s F-12 plus 10% fetal bovine serum (FBS) without an-
tibiotics. Various control and knockout mouse embryonic fibroblasts 
(PERK+/+ and PERK−/− [Harding et al., 2000]); IRE1α+/+ and IRE1α−/− 
[Urano et al., 2000]; XBP1+/+ and XBP1−/− [Lee et al., 2003]; and 
MPI+/+ [DeRossi et al., 2006]) were cultured in RPMI 1640 medium 
plus 10% FBS without antibiotics, unless indicated otherwise. How-
ever, all siRNA incubations used DMEM plus 10% FBS for more op-
timal knock-down. Gelatin-coated dishes were used for all cells in 
experiments involving PERK−/− MEFs treated with DTT or TG, which 
was necessary to maintain good adhesion of these cells when under 
ER stress (Shang et al., 2007). Phenotypes of MEF lines with ho-
mozygous disruptions of the PERK and IRE1α genes were indepen-
dently verified by the lack of immunologically detectable PERK or 
IRE1α, and the absence of stress-dependent formation of P-eIF2α 
or spliced XBP1 mRNA, respectively.
FACE analyses of LLO glycans, free glycans, nucleotide 
sugars, and monosaccharide phosphates
Published methods were followed (Gao and Lehrman, 2002a, 2003, 
2006). Briefly, LLOs were recovered in chloroform:methanol:water 
(10:10:3) extracts, after which glycans were released with mild acid. 
Free glycans, monosaccharide phosphates, and nucleotide sugars 
(eventually yielding free neutral hexoses) were recovered in aque-
ous extracts, and separated by anion exchange. Hexose-1-phos-
phates and nucleotide sugars were then selectively hydrolyzed to 
neutral hexoses, leaving hexose-6-phosphates unaffected. Glycans 
were conjugated with ANDS and separated with oligosaccharide 
profiling gels, while neutral hexoses and hexose-6-Ps were conju-
gated with AMAC and resolved with monosaccharide profiling (bo-
rate) gels. Where indicated, ANDS-conjugated glycans were di-
gested with endoglycosidase H or jack bean α-mannosidase prior to 
electrophoresis. Per 107 cells, 5% of the sample for monosaccharide 
analysis, and 50% of the sample for glycan analysis, was usually 
loaded per gel lane.
For FACE data analysis, gel images were acquired with a Bio-Rad 
Fluor-S MultiImager using a 530DF60 filter (Hercules, CA). When 
necessary, individual bands of ANDS and AMAC conjugates on gels 
were located and quantified with Quantity One software supplied 
with the scanner. Alternatively, entire pools of ANDS-conjugated 
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underlined in primers listed below): 5′-TTTCCTACTAGTCT-
GAGCGTGCATCAGCAG-3′ (forward for both constructs) and ei-
ther 5′-TTTCCTACTAGTCTCCAGGCTCCAGAAGAAGG-3′ (reverse 
for kinase plus RNase) or 5′-TTTCCTACTAGTGAGGGCATATG-
GAATCACTG-3′ (reverse for kinase only). Both cDNA fragments 
were ligated (Rapid DNA Ligation Kit, #11635379001; Roche) into 
SpeI-digested pC4-Fv1E (a kind gift from Ariad Pharmaceuticals) and 
transformed into Escherichia coli. Plasmid inserts were screened 
by SpeI digestion, and orientations were verified by both XhoI diges-
tion and DNA sequencing. Spurious point mutations were corrected 
with the QuikChange II Site-Directed Mutagenesis Kit (#200523; 
Stratagene, Agilent Technologies, Santa Clara, California) and rese-
quenced. Plasmids preparation, PCR product purification, and DNA 
digest extraction were done with Qiagen products (Valencia, CA): 
Spin Miniprep Kit, PCR Purification Kit, and Gel Extraction Kit.
Selection of stable transfectants
Plasmids encoding the kinase domain only (designated pC4Fv-1E-K, 
abbreviated pK) or the kinase plus RNase domain (pC4Fv-1E-K+R, 
pK+R), or the empty vector pC4Fv-1E were cotransfected in 10-fold 
excess with plasmid pMAM-neo for stable selection into CHO-K1 
cells with FuGENE HD Transfection Reagent (#04709691001; Roche). 
Well-separated single colonies were picked with cloning cylinders af-
ter selection with 800 µg/ml G418. Colonies were screened for rela-
tive expression levels and sizes of IRE1α fusion proteins by immuno-
blotting detergent extracts with anti-HA antibody to detect the HA 
epitope tag fused to the C-termini of the encoded proteins by the 
pC4Fv-1E vector. The colonies with highest expression levels of kinase 
only or kinase plus RNase fusion proteins were designated pK5 and 
pK+R11, respectively, and were used in all experiments presented 
here (a pK sibling transfectant with fivefold lower levels of fusion pro-
tein than pK5 gave a similar response to AP20187, as in Figure 9C).
Immunoblotting
Cells grown in 100-mm dishes were lysed with 0.3–0.4 ml RIPA 
buffer (150 mM sodium chloride, 1.0% NP-40, 0.5% sodium deoxy-
cholate, 0.1% SDS, 50 mM Tris, pH 8.0) supplemented with protease 
inhibitors (Complete Mini Protease Inhibitor Cocktail Tablets, 
#11836153001; Roche) and phosphatase inhibitors (PhosSTOP, Phos-
phatase Inhibitor Cocktail Tablets, #04906837001; Roche), one tablet 
each per 10 ml buffer. After vortexing, lysates were kept on ice for 
30 min, then clarified by centrifugation. Protein was measured with a 
BCA protein assay kit (#23225; Pierce, Thermo Fisher Scientific, 
Rockford, IL). Lysate protein (15–40 µg) was subjected to SDS–PAGE 
with single acrylamide concentrations from 6–10%. Proteins were 
transferred to Protran nitrocellulose membrane (Whatman, Piscat-
away, NJ), blocked with Tris-buffered saline (TBS)-T (20 mM Tris-Cl, 
pH 7.6, 137 mM NaCl, 0.1% Tween-20) containing 5% nonfat milk, 
and probed with antibodies prediluted in TBS-T containing 5% bo-
vine serum albumin (BSA; #001-000-162; Jackson ImmunoResearch 
Laboratories, West Grove, PA) with overnight incubation at 4ºC. Tar-
get proteins were detected with Amersham ECL Western Blotting 
Detection Reagents (#RPN2109, Amersham, GE Healthcare) and vi-
sualized by exposure to X-ray film, scanning with a Bio-Rad Fluor-S 
MultiImager, and processing with Bio-Rad Quantity-One software.
XBP1 Splicing
Total mRNA (RNeasy; Qiagen, Valencia, CA) isolated after the indi-
cated treatment was used for a PCR-based assay to assess XBP1 
mRNA splicing (Shang and Lehrman, 2004). PCR products repre-
senting spliced XBP1, unspliced XBP1, and a hybrid formed during 
the chain reaction (denoted with the subscripts S, U, and H, respec-
tively) were resolved by agarose gel electrophoresis.
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